Dyne Therapeutics, Inc.

DYNCIK 0001818794 · Every Form 4 filed by insiders at this issuer.

Filings

16

Latest Mar 27, 2024

Unique insiders

13

Showing

16 of 16

Page 1

Top insiders

Most active reporters at Dyne Therapeutics, Inc.

All filings

16 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 27, 2024
Cox John
See Remarks · Director
Holdings only
Mar 13, 2024
HIGH SUSANNA GATTI
Chief Operating Officer
S26,908$26.66$717,367
Mar 12, 2024
Brumm Joshua T
CEO & President · Director
S202,238$25.30$5,116,621
Mar 11, 2024
HIGH SUSANNA GATTI
Chief Operating Officer
S1,591$25.85$41,127
Mar 11, 2024
Brumm Joshua T
CEO & President · Director
S9,086$25.85$234,873
Mar 5, 2024
Atlas Venture Opportunity Fund I, L.P.
10% Owner
S29,435$30.05$884,522
Mar 5, 2024
Rhodes Jason P
Director
S29,435$30.05$884,522
Mar 1, 2024
Brumm Joshua T
CEO & President · Director
S74,090$29.23$2,165,651
Feb 28, 2024
Atlas Venture Fund XI, L.P.
10% Owner
S272,923$24.38$6,653,863
Feb 28, 2024
Rhodes Jason P
Director
S272,923$24.38$6,653,863
Feb 23, 2024
Atlas Venture Fund XI, L.P.
10% Owner
S159,542$22.70$3,621,603
Feb 23, 2024
Rhodes Jason P
Director
S159,542$22.70$3,621,603
Feb 20, 2024
Atlas Venture Fund XI, L.P.
10% Owner
S175,793$23.88$4,197,937
Feb 20, 2024
Rhodes Jason P
Director
S175,793$23.88$4,197,937
Jan 31, 2024
Brumm Joshua T
CEO & President · Director
G20,000$0.00$0
Jan 4, 2024
Brumm Joshua T
CEO & President
S180,235$18.40$3,316,324

Showing 116 of 16

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.